Raj Denhoy
Stock Analyst at Jefferies
(3.03)
# 1,370
Out of 4,975 analysts
55
Total ratings
68.09%
Success rate
24.45%
Average return
Main Sectors:
Stocks Rated by Raj Denhoy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterates: Hold | $120 | $132.94 | -9.73% | 5 | Sep 26, 2024 | |
| EW Edwards Lifesciences | Maintains: Buy | $110 → $130 | $80.94 | +60.61% | 10 | Jul 30, 2021 | |
| HOLX Hologic | Maintains: Buy | $106 → $110 | $66.76 | +64.77% | 9 | Apr 5, 2021 | |
| PROF Profound Medical | Initiates: Buy | n/a | $4.12 | - | 1 | Sep 15, 2020 | |
| DXCM DexCom | Maintains: Buy | $29 → $31 | $80.51 | -61.18% | 8 | Aug 2, 2018 | |
| AXGN Axogen | Initiates: Buy | $35 | $15.98 | +119.02% | 1 | Nov 30, 2017 | |
| TFX Teleflex | Maintains: Buy | $270 → $295 | $130.70 | +125.71% | 9 | Nov 3, 2017 | |
| LIVN LivaNova | Maintains: Buy | $80 → $91 | $58.00 | +56.91% | 3 | Nov 3, 2017 | |
| LNTH Lantheus Holdings | Maintains: Buy | $22 → $27 | $54.75 | -50.68% | 2 | Nov 3, 2017 | |
| PODD Insulet | Maintains: Buy | $58 → $67 | $348.43 | -80.77% | 7 | Nov 3, 2017 |
Abbott Laboratories
Sep 26, 2024
Reiterates: Hold
Price Target: $120
Current: $132.94
Upside: -9.73%
Edwards Lifesciences
Jul 30, 2021
Maintains: Buy
Price Target: $110 → $130
Current: $80.94
Upside: +60.61%
Hologic
Apr 5, 2021
Maintains: Buy
Price Target: $106 → $110
Current: $66.76
Upside: +64.77%
Profound Medical
Sep 15, 2020
Initiates: Buy
Price Target: n/a
Current: $4.12
Upside: -
DexCom
Aug 2, 2018
Maintains: Buy
Price Target: $29 → $31
Current: $80.51
Upside: -61.18%
Axogen
Nov 30, 2017
Initiates: Buy
Price Target: $35
Current: $15.98
Upside: +119.02%
Teleflex
Nov 3, 2017
Maintains: Buy
Price Target: $270 → $295
Current: $130.70
Upside: +125.71%
LivaNova
Nov 3, 2017
Maintains: Buy
Price Target: $80 → $91
Current: $58.00
Upside: +56.91%
Lantheus Holdings
Nov 3, 2017
Maintains: Buy
Price Target: $22 → $27
Current: $54.75
Upside: -50.68%
Insulet
Nov 3, 2017
Maintains: Buy
Price Target: $58 → $67
Current: $348.43
Upside: -80.77%